Data / Form D filings / Silexion Therapeutics Corp
Silexion Therapeutics Corp: Form D filing
Silexion Therapeutics Corp, a biotechnology company in Ramat Gan, Israel, filed a Form D with the SEC in 2025. The latest, on August 11, 2025, reports $3.6 million sold of a $3.6 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12 ABBA HILLEL ROAD, Ramat Gan, Israel, 52506
- Phone
- +972-3-756-4999
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Cayman Islands
- Year incorporated
- 2024
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2022416
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 11, 2025 | New notice | $3,597,662 | $3,597,662 | 11 | Aug 1, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mirit Horenshtein-Hadar | Executive Officer | |
| Amnon Peled | Director | |
| Mitchell Shirvan | Executive Officer | |
| Shlomo Noy | Director | |
| Ruth Alon | Director | |
| Ilan Levin | Director | |
| Avner Lushi | Director | |
| Dror Abramov | Director | |
| Ilan Hadar | Executive Officer, Director |
Every Form D from the week of Aug 11, 2025 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Silexion Therapeutics Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.